Diagnostic performance of prostate imaging reporting and data system version 2 for detection of prostate cancer: a systematic review and diagnostic meta-analysis

S Woo, CH Suh, SY Kim, JY Cho, SH Kim - European urology, 2017 - Elsevier
Abstract Context In 2015, the updated Prostate Imaging Reporting and Data System version
2 (PI-RADSv2) for the detection of prostate cancer (PCa) was established. Since then …

A systematic review of the existing prostate imaging reporting and data system version 2 (PI-RADSv2) literature and subset meta-analysis of PI-RADSv2 categories …

EJ Barkovich, PR Shankar… - American Journal of …, 2019 - Am Roentgen Ray Soc
OBJECTIVE. The objective of this study was to quantitatively and qualitatively assess the
methodologic heterogeneity of the current Prostate Imaging Reporting and Data System …

Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology

A Priester, S Natarajan, P Khoshnoodi… - The Journal of …, 2017 - auajournals.org
Purpose: We evaluated the accuracy of magnetic resonance imaging in determining the size
and shape of localized prostate cancer. Materials and Methods: The subjects were 114 men …

Multiparametric MRI for prostate cancer characterization: Combined use of radiomics model with PI-RADS and clinical parameters

P Woźnicki, N Westhoff, T Huber, P Riffel, MF Froelich… - Cancers, 2020 - mdpi.com
Radiomics is an emerging field of image analysis with potential applications in patient risk
stratification. This study developed and evaluated machine learning models using …

[HTML][HTML] What type of prostate cancer is systematically overlooked by multiparametric magnetic resonance imaging? An analysis from the PROMIS cohort

JM Norris, LMC Echeverria, SRJ Bott, LC Brown… - European urology, 2020 - Elsevier
Background All risk stratification strategies in cancer overlook a spectrum of disease. The
Prostate MR Imaging Study (PROMIS) provides a unique opportunity to explore cancers that …

Transperineal US-MRI fusion-guided biopsy for the detection of clinical significant prostate cancer: a systematic review and meta-analysis comparing cognitive and …

GM Pirola, D Castellani, L Orecchia, C Giulioni… - Cancers, 2023 - mdpi.com
Simple Summary US-MRI fusion biopsy is established as a technique of reference for the
detection of clinically significative prostate cancer compared to the ultrasound “template” …

Diagnostic accuracy and interobserver agreement of PI-RADS version 2 and version 2.1 for the detection of transition zone prostate cancers

C Wei, Y Zhang, P Pan, T Chen, H Yu… - American Journal of …, 2021 - Am Roentgen Ray Soc
BACKGROUND. PI-RADS version 2.1 (v2. 1) introduced a number of key changes to the
assessment of transition zone (TZ) lesions. OBJECTIVE. The purpose of this study was to …

Biparametric versus Multiparametric MRI with Non-endorectal Coil at 3T in the Detection and Localization of Prostate Cancer

M Scialpi, E Prosperi, A D'ANDREA… - Anticancer …, 2017 - ar.iiarjournals.org
Aim: To assess the sensitivity of biparametric magnetic resonance imaging (bpMRI) with non-
endorectal coil in the detection and localization of index (dominant) and non-index lesions in …

PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer?

L Rico, L Blas, G Vitagliano, P Contreras… - … Oncology: Seminars and …, 2021 - Elsevier
Introduction Currently, a new subclassification of the Pi-RADS 3 lesions and subgroups is
being used: 3a (indolent or low-risk lesions with volume< 0.5 ml) and 3b (significant or high …

[HTML][HTML] Biparametric MRI of the prostate

M Scialpi, A D'Andrea, E Martorana… - Turkish journal of …, 2017 - ncbi.nlm.nih.gov
Abstract Biparametric Magnetic Resonance Imaging (bpMRI) of the prostate combining both
morphologic T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) is emerging …